Literature DB >> 9798020

Mechanisms and management of antibiotic-associated diarrhea.

C Högenauer1, H F Hammer, G J Krejs, E C Reisinger.   

Abstract

Only 10%-20% of all cases of antibiotic-associated diarrhea (AAD) are caused by infection with Clostridium difficile. Other infectious organisms causing AAD include Clostridium perfringens, Staphylococcus aureus, Klebsiella oxytoca, Candida species, and Salmonella species. Most of the clinically mild AAD cases are due to functional disturbances of intestinal carbohydrate or bile acid metabolism, to allergic and toxic effects of antibiotics on intestinal mucosa, or to pharmacological effects on motility. Saccharomyces boulardii and Enterococcus SF68 can reduce the risk of developing AAD. Patients receiving antibiotic treatment should avoid food containing high amounts of poorly absorbable carbohydrates. Mild cases of AAD that may or may not be caused by C. difficile can be resolved by discontinuation of antibiotic therapy and by dietary carbohydrate reduction. Only severe AAD caused by C. difficile requires specific antibiotic treatment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9798020     DOI: 10.1086/514958

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  74 in total

1.  The underuse of probiotics by family physicians.

Authors:  L Edmunds
Journal:  CMAJ       Date:  2001-05-29       Impact factor: 8.262

2.  [Nosocomial diarrhea].

Authors:  S Weis; M Grimm
Journal:  Internist (Berl)       Date:  2011-02       Impact factor: 0.743

3.  Managing antibiotic associated diarrhoea.

Authors:  Frédéric Barbut; Jean Luc Meynard
Journal:  BMJ       Date:  2002-06-08

4.  Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota.

Authors:  Vincent B Young; Thomas M Schmidt
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

5.  Bacterial diversity in intestinal mucosa of antibiotic-associated diarrhea mice.

Authors:  Guozhen Xie; Kai Tan; Maijiao Peng; Chengxing Long; Dandan Li; Zhoujin Tan
Journal:  3 Biotech       Date:  2019-11-09       Impact factor: 2.406

6.  Enterotoxicity of a nonribosomal peptide causes antibiotic-associated colitis.

Authors:  Georg Schneditz; Jana Rentner; Sandro Roier; Jakob Pletz; Kathrin A T Herzog; Roland Bücker; Hanno Troeger; Stefan Schild; Hansjörg Weber; Rolf Breinbauer; Gregor Gorkiewicz; Christoph Högenauer; Ellen L Zechner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

7.  Clinical outcomes, safety, and pharmacokinetics of OPT-80 in a phase 2 trial with patients with Clostridium difficile infection.

Authors:  T Louie; M Miller; C Donskey; K Mullane; E J C Goldstein
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

8.  Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.

Authors:  Jacques Pépin; Louis Valiquette; Marie-Eve Alary; Philippe Villemure; Annick Pelletier; Karine Forget; Karine Pépin; Daniel Chouinard
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

9.  Effects of Clostridium perfringens alpha-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues.

Authors:  David K O'Brien; Stephen B Melville
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

10.  [Antibiotic induced diarrhea and pseudomembranous colitis].

Authors:  C Greb; T Kalem; T Kälble
Journal:  Urologe A       Date:  2002-12-19       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.